Most people notice appetite changes within the first 2 to 4 weeks, even at the 0.25 mg initiation dose
They found that, as expected, 5-amino-1MQ altered the levels of proteins that were different from those seen with exercise training alone
Much of the current evidence is preclinical (cell and animal studies), and human data is still limited
SS-31 (Elamipretide) Description: A mitochondrial-targeting peptide that protects and repairs cellular energy systems, reduces oxidative stress, and improves energy levels
Those pregnant, breastfeeding, or undergoing cancer treatment should avoid it until more data becomes available
Physical symptoms may include weakness, pale or yellowish skin, numbness or tingling in extremities, balance difficulties, mood changes including depression or irritability, and tongue inflammation